Since 2014, medical industry payment data to physicians have been public via the Open Payments database. Patient opinions regarding these data help us to understand concerns and policymakers to improve reporting mechanisms for such payments.
T he Open Payments database was established in 2014 by the Center for Medicare and Medicaid Services to provide greater transparency of physician and hospital relationships with industry. 1 Any payments or transfer of value to physicians and hospitals from industry are reported and available online to the public. Payments are divided into multiple categories, such as consulting, royalties, speaker honoraria, food, travel, gifts and charitable contributions, and research support. In the first 5 months in which Open Payments data were collected (August 1, 2013, to December 31, 2013), 55 996 individual payments were made to 9855 ophthalmologists.
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It is unclear if patients are interested in receiving these data and how they view, interpret, and value this information. Recent studies suggested that even small industry payments are correlated with increased usage of associated medications, even if causation is still unclear. [3] [4] [5] In this study, we sought to determine how patients in an ophthalmology practice felt about professional relationships between physicians and the drug and medical device industries.
Further understanding of what patients find to be important may aid in improving the data reporting system and may make physicians aware of how this information is perceived by the public.
Methods
This was a cross-sectional analysis of patients receiving ophthalmic care at Columbia University Medical Center in New York City, New York. Institutional review board approval was obtained for the facility where the study was conducted. Participants were given information about the study and gave verbal consent prior to survey completion. The study was compliant with the Health Insurance Portability and Accessibility Act, and the research adhered to the tenets of the Declaration of Helsinki. 6 
Eligibility
Prospective participants were patients of the ophthalmology service at Columbia University Medical Center. Patients were approached in the waiting rooms of 2 different floors within the Eye Institute at the main campus in Washington Heights and at a satellite clinic in Midtown Manhattan. Eligible participants had to be at least 18 years of age. All adult patients who expressed understanding of informed consent and stated that they had not previously participated were eligible. Most participants were recruited and enrolled by one physician (G.E.S.). The physician for a particular participant was not tracked to instill participant confidence that answers would be anonymous.
Completion of the Questionnaire
The questionnaire was developed with the goal of understanding patient perception while limiting response bias and ensuring anonymity. The authors and other physicians in the academic department composed the questions. Responses were anonymous. Patients were asked if they had previously completed the questionnaire to prevent multiple responses. There was no compensation for completing the survey.
Participants were given background information about the study, and verbal informed consent was obtained. To limit external influence, participants who had questions about individual survey items after starting the survey were instructed to answer the question as best as they thought they could. The informed consent agreement is provided in eAppendix 1 and eAppendix 2 of the Supplement.
Participants had the option of completing the consent and questionnaire in English or Spanish. Spanish-language documents were approved by the Spanish Translation Center at Columbia University Medical Center. Most participants completed the questionnaire in the clinic, while a few took it home and returned it at their next visit; this rate was not measured.
Questionnaire
Demographic information made up the first 5 questions. Participants were asked about age, sex, highest level of education achieved, health insurance, and subjective sense of vision. Regarding vision, participants were asked if they had no visual impairment, had visual impairment but were able to perform routine activities independently, or had visual impairment that necessitated assistance for daily tasks.
Patients were asked if they were aware of the Open Payments database or Sunshine Act, and if they had tried to or planned to access the database. Participants were also asked if they were physicians themselves.
A series of questions asked patients if they agreed, disagreed, or had no opinion about wanting to know if their physician or his or her staff received gifts, meals, or payments of any kind from a drug or medical device company. A second series of questions asked if patients approved, disapproved, or had no opinion about their physician accepting meals, travel reimbursement, gifts, books, royalties, or other payments from a drug or medical device company. Several of these questions were qualified by the physician receiving payment to learn about the product, explain a product to others, or give an expert opinion. Last, a series of questions were aimed at identifying the quantity of payments that would be acceptable to patients. Patients were asked if they approved, disapproved, or had no opinion about their physician receiving payments of $100, $500, $1000, $10 000, $50 000, or $100 000. English and Spanish versions of the questionnaire are in eAppendix 3 and eAppendix 4 in the Supplement.
Statistical Methods
Power analysis was performed and suggested that a sample size of 400 was enough to demonstrate statistical significance with a 5% margin of error and a 95% confidence level. Reliability and internal consistency are key steps for the validation of questionnaires aimed to assess patient-related outcomes, as recommended by the US Food and Drug Administration (FDA).
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A separate validation should be performed for questionnaires in different languages. Therefore, to assess the reliably and internal consistency of our newly developed questionnaire, Cronbach α was calculated for the English and Spanish versions of the survey. General and FDA guidelines recommend a Cronbach α of .70 to .95. 8 Answers were placed into categories of approval, disapproval, or no opinion. A composite score of approval for each participant was calculated. These data were analyzed with Poisson regression analysis to determine if certain background variables were associated with the likelihood of approval of receiving payments from medical industry. Univariable Poisson linear regression analysis was used to look for an association between background data and likelihood of approval for each variable. Next, multivariable Poisson regression analysis was performed to search relationships between background criteria and likelihood of approval. Predictors with P < .25 from the univariable analysis were tested in the multivariable analysis. For each background variable, an incidence rate ratio (IRR) as well as the P value and 95% confidence interval were calculated. The IRR can be interpreted as the likelihood of approval of payments to physicians compared with the reference variable.
All tests were 2-sided, and P < .05 was considered significant. Statistical analysis was performed with Stata version 14 (StataCorp LP). Data was collected from January to June 2016, and the analysis was performed from June to September 2016.
Results

Baseline Characteristics
A total of 407 patients participated in the study. 
Responses to Information in the Open Payments Database
More than half of all participants (n = 212; 53.5% [95% CI, 48.6%-54.5%]) agreed with the statement that they would like to know if their physician receives payments of any value. Roughly one-third wanted to know that their physician accepted a meal for himself or herself (n = 128; 32.2% [95% CI, 27.6-36.8]) or for their office staff (n = 138; 34.4% [95% CI, 29.8-39.1]). Slightly more than half of all participants wanted to know Table 3 ).
Patients expressed a range of opinions about whether they approved, disapproved, or had no opinion about certain payments to physicians that are reported in the database (Table 3) When the value of the transfer to physicians was presented as an amount, disapproval increased with increasing value of the transfer. Nearly half of the participants (n = 161; 41.9% [95% CI, 37.0%-46.9%]) disapproved of their physician receiving $100 per year in payments of any kind from the medical industry, and this increased to 221 participants (57.0%; 95% CI, 52.0%-61.9%) for payments of $25 000 per year ( Figure) .
Reliability and Regression Analysis
Cronbach α, a measurement of the reliability of an instrument, was calculated for both language versions of the questionnaire. In this study, it can be interpreted as the reliability of the questionnaire at measuring patient approval or disapproval of data associated with the Open Payments Database. Cronbach α was .89 for the English version and .95 for the Spanish version of the questionnaire, suggesting excellent reliability.
A univariate model was constructed with Poisson regression models and IRRs were calculated. This can be interpreted as the likelihood of an event occurring. An IRR greater than 1 indicates that the group is more likely to approve of physicians receiving payments and an IRR less than 1 indicates that the group is more likely to disapprove of physicians receiving payments.
In the univariate model, the association between background variables and IRRs was tested without controlling for any factors. Participants who took the survey in Spanish were 34% more likely to approve of physicians receiving payments (IRR, 1.34 [95% CI, b Participants were asked to mark "agree," "disagree," or "no opinion."
c Participants were asked to mark "approve," "disapprove," or "no opinion." likely to approve of physicians receiving payments than were those with less than a high school education, respectively. Those who were aware of the database, and who had already tried to search for the database, were also more likely to disapprove of physicians receiving payments from pharmaceutical and medical device industries.
In the final multivariable regression analysis, we included only those variables with P < .25 from the univariate model. We found that those who took the survey in Spanish were 38% more likely to approve of physicians receiving payments (IRR, 1.38 [95% CI, 1.19-1.59]; P < .001). In this model, there was no longer a statistically significant association with sex. Again in this model, participants were 1% less likely to approve of physicians receiving payments from industry for each year of age (IRR, 0.995 [95% CI 0.99-1.00]; P = .01). Those who completed graduate school were 20% less likely to approve than those who completed less than college (IRR, 0.80 [95% CI, 0.66-0.97]; P = .02). Those who stated that they were aware of the database were 16% less likely to approve of physicians receiving payments (IRR, 0.84 [95% CI, 0.70-1.00]; P = .047; Table 4 ).
Discussion
While the association between marketing and physician behavior had been previously reported, Open Payments data have been used in combination with other Centers for Medicare and Medicaid Services data to evaluate physician behavior. Several recent reports have concluded that there is an association between pharmaceutical payments and the selection of anti-vascular endothelial growth factor agents. 3, 5 This form of industry influence has also been reported in other specialties of medicine. 4 This study revealed that the surveyed patients were concerned about their physicians receiving industry payments. Consistent with this set of beliefs, patient disapproval increased as the total value of the payment increased. Other studies also concluded that a significant percentage of patients would like to know about their physicians receiving payments. 9 Our results demonstrated that disapproval of this behavior was positively associated with education and age, similar to previous findings. 10, 11 This may be particularly impactful for ophthalmologists, who see a large share of patients older than 65 years. We included subjective sense of vision as a background characteristic, because we hypothesized that patients with greater vision loss might be less concerned about involvement with medical industry. Our results showed no association between subjective sense of vision and patient opinions.
The findings may be applicable to all areas of medicine, because ophthalmology patients likely interact with other physicians. As both a medical and surgical subspecialty, ophthalmology is in a unique position, because potential conflicts of interest may occur with brand-name and high-cost medications as well as use of surgical devices and techniques. Therefore, ophthalmologists may be under higher scrutiny by patients regarding these financial relationships.
While many patients were concerned about remuneration from the medical industry, other findings suggested the influence of the database is limited at the present. Our results showed a lack of awareness of Open Payments data. These results are consistent with a survey study by Pham-Kanter et al, 12 examining if patients were treated by health care professionals who had received payments in the Open Payments database. In their study, 12% of respondents, compared with 8% in our survey, were aware of the database. Generally, in both studies, patients were of similar education background and were primarily urban-dwelling. In this study, we had a slightly older population, with higher rates of Medicare and Medicaid coverage. In our data, patients disapproved of the physician and staff receiving payments at similar rates of disapproval to the same behavior conducted by the physician alone. This is important because Open Payments may undervalue meals provided to staff; perhaps this omission should be corrected in the future. 13 Fewer respondents, though still a large percentage, disapproved when payments were tied to a specific task, such as lecturing, consulting, education, or development of intellectual property.
Patients who took the survey in Spanish were more likely to approve of payments than their counterparts who took the survey in English. This finding was significant after controlling for education and may reflect a cultural difference in physician perception. A high correlation between language and education in our respondents made it difficult to truly separate these 2 variables, however, because of the significant association between participant education level and the language chosen for survey completion.
Limitations
A measurement error may affect any survey, because answers may not reflect what participants actually believe or would do outside of the survey.
14 The responses in this study could be influenced by participants learning about Open Payments in the survey questions or during the informed consent. We tried to limit error by explaining the Open Payments Database in a brief and concrete way, so that respondents could understand the purpose of the study and agree to participant. Patient recruitment in a systematic fashion was reinforced because 1 physician did nearly all of the enrollment. Our analysis of the survey, demonstrated by the high Cronbach α, showed that it was a reliable instrument. The study population was participants in New York City during 2016, and different results could have been observed in another place or time. Compared with the US population, our study sample had a high graduate degree completion rate (28.2%). Opinions of individuals who were not involved in ophthalmic care were excluded from this survey population. Survey respondents may have been slightly younger and healthier than a general ophthalmology practice distribution, possibly because older and sicker patients declining survey participation. More respondents (40%) had Medicaid coverage than the national mean, which was 19.4% in 2016. 15 Political affiliations were not investigated in this survey. Because New York City may be more liberal and/or Democratic than other areas of the country, this may affect the generalizability of the results. However, to our knowledge, patient opinions on this topic and correlation with political party affiliation have not been measured. Also, party affiliation may not dictate opinions on single issues. Finally, the practice catchment area includes the New York, New Jersey, and Connecticut metropolitan area, which is ethnically and socioeconomically diverse. Generalizability could certainly be improved by including participants from a wider area, but it seems reasonable to conclude that a nontrivial percentage of patients has concerns about financial relationships between physicians and industry.
Conclusions
Industry interactions are part of medical care and important to advancing the ophthalmologic field. However, some argue that public interests may be undermined if they are not aligned with the financial interests of the medical industry. 16 Disclosures aim to increase awareness of pharmaceutical industry involvement. Critics of disclosure argue that the effect of disclosure is limited and that more needs to be done. 16 Ironically, disclosure may actually engender trust, because the physician is perceived as being very honest about his relations with industry.
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The results from this study show that this patient cohort felt that physicians should generally avoid financial interactions with industry. However, it appears that many did not access the Open Payments database, and it is unclear if or when they will. Incorporating patient concerns may guide the government to more effectively report this information. It behooves ophthalmologists to understand how industry interactions are reported and how this information affects the relationships of physicians with patients. The intention of the Physician Payments Sunshine Act (PPSA) was to bring transparency to the financial payments that health care clinicians receive from the medical industry. 1 The act's leading proponents, Sens Chuck Grassley (Iowa) and Herb Kohl (Wisconsin), hoped that the public disclosure of industry payments to physicians would ultimately lead to lower health care costs. That result was to come from informed patients discussing with their physicians the physicians' relationships with the medical industry. In turn, the scrutiny would make physicians reluctant to have those relationships, thereby reducing the medical industry's influence on the prescription of high-cost medications.
Whether and how patients deal with open payments has led to numerous studies, such as the article by Stein et al 2 in this issue of JAMA Ophthalmology. The authors were interested in whether patients were aware of ways in which they could find information about their physicians' financial relationships with the medical industry and in determining patients' attitudes toward physician-industry financial relationships. The study participants were patients who were recruited from 3 different waiting rooms of an academic medical center while waiting to see their physicians. The participants completed a written questionnaire that focused on 2 general issues: (1) patients' knowledge of the PPSA and its mandated Open Payments program in which certain industry payments to physicians are recorded in a database that is open to the public and (2) patients' interest in knowing whether their physicians receive industry payments and patients' attitude toward such payments. The study found that of the 407 participants, fewer than 30 (7.3%) knew of the PPSA or of its Open Payments database and just 12 (3%) had made an effort to look at it; however, once informed of the database's existence, 109 (27%) indicated an interest in exploring it. Most participants (212 [52%]) wanted to 
Introduction and Research Purpose
We are initiating a research study to learn more about how patients view the relationship that their doctor has with the medical industry. We are also interested in learning about patient awareness and opinions of the Open Payments database. Ultimately this information could inform doctors and policy about patient preferences. The researcher will only have access to the data provided in your survey. This data will be de-identified. In other words, the data will not have your name, medical record number, date of birth or other information with which we can associate the survey data with you. The research may collect information related to your medical history. Please note that the survey includes a question about your vision and age.
Whether or not you choose to participate in the survey, your medical care will not be affected.
Confidentiality
Data from the survey will be submitted anonymously, and we will not be able to associate data from the survey with your name. Although every effort will be made to protect the confidentiality of the survey, confidentiality cannot be guaranteed. Also, according to the rules governing research procedures at Columbia, by agreeing to participate in the study, you grant permission for information about you obtained during the study to be made available to:
The investigator and members of their study team, Authorities at Columbia University Medical Center including the Institutional Review Board (IRB) who independently review studies to assure adequate protection of research participants, as required by federal regulations, The Federal Office of Human Research Protections (OHRP) and other government agencies that oversee the safety of human subjects. P any reason. To revoke this authorization you must contact the Principal Investigator, Jonathan Chang M.D., at (212) 305 9535. However, even if you revoke this authorization, the researchers may continue to use and disclose the information already collected, however new information will not be collected for this research purpose. Use of this information / your HIPAA authorization will expire at the end of this research.
Investigador Principal: Dr. Jonathan Chang Título del Protocolo de la IRB: Percepciones del paciente de los Pagos Abiertos
Introducción y objetivo de la Investigación
Estamos iniciando un estudio de investigación para entender más sobre la forma en la cual los pacientes ven la relación de su médico con la industria de la medicina. También estamos interesados en aprender más sobre el conocimiento y las opiniones de los pacientes sobre la P A O P E poner al corriente a los médicos y los políticos sobre las preferencias de los pacientes. El investigador sólo tendrá acceso a la información que usted proporcione en su cuestionario. Esta información será anónima; en otras palabras, la información no tendrá ni su nombre, número del historial médico, fecha de nacimiento ni otra información con la cual podamos asociar sus respuestas de la encuesta con usted. Esta investigación podría recopilar información relacionada con su historial médico. Tenga en cuenta que el cuestionario incluye una pregunta sobre su edad y su visión.
Si usted decide participar o no participar en este cuestionario, su cuidado médico no se verá afectado.
Confidencialidad
La información del cuestionario es anónima y nosotros no podremos asociar la información de la encuesta con su nombre. Si bien tomaremos todas las medidas para proteger la confidencialidad de la encuesta, no podemos garantizarlo. Además, de acuerdo con las reglas que gobiernan los procedimientos de investigación en Columbia, al aceptar participar en este estudio, usted otorga permiso para que la información obtenida de usted durante el estudio esté disponible para:
El investigador y los miembros de su grupo del estudio, las autoridades del Centro Médico de la Universidad de Columbia incluyendo la Comisión Institucional de Revisión (IRB por sus siglas en inglés) quien de manera independiente revisa los estudios para garantizar la protección adecuada de los participantes en investigación, como es requerido por las regulaciones federales, la Oficina de Protección de Humanos en la Investigación (OHRP por sus siglas en inglés) a nivel federal y otras entidades gubernamentales que supervisan la seguridad de los Ningún impedimento visual Impedimento visual, pero puedo realizar las actividades de rutina en forma independiente Impedimento visual y necesito ayuda para realizar las actividades diarias
